(Q73195343)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11080561%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

The global diabetes model: user friendly version 3.0. (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11080561%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

J B Brown

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11080561%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A Russell

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11080561%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

W Chan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11080561%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

K Pedula

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11080561%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M Aickin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11080561%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 November 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11080561%20AND%20SRC:MED&resulttype=core&format=json

Diabetes Research and Clinical Practice

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11080561%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

50 Suppl 3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11080561%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

S15-46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11080561%20AND%20SRC:MED&resulttype=core&format=json

Cardiovascular disease risk profiles.

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900215-1

7 January 2021

Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900215-1

7 January 2021

Representativeness of the Framingham risk model for coronary heart disease mortality: a comparison with a national cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900215-1

7 January 2021

Using the Framingham model to predict heart disease in the United Kingdom: retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900215-1

7 January 2021

Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900215-1

7 January 2021

Prediction of Coronary Heart Disease Using Risk Factor Categories

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900215-1

7 January 2021

Diabetic dyslipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900215-1

7 January 2021

A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes. The Atherosclerosis Risk in Communities (ARIC) Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900215-1

7 January 2021

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900215-1

7 January 2021

Mortality in older people with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900215-1

7 January 2021

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900215-1

7 January 2021

Impact of cardiovascular disease on health care utilization in a defined diabetic population.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900215-1

7 January 2021

Medical Care Costs and Quality of Life after Randomization to Coronary Angioplasty or Coronary Bypass Surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900215-1

7 January 2021

Risk factors for long-term coronary prognosis after initial myocardial infarction: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900215-1

7 January 2021

Model of complications of NIDDM. I. Model construction and assumptions.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900215-1

7 January 2021

Chronic renal failure in non-insulin-dependent diabetes mellitus. A population-based study in Rochester, Minnesota.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900215-1

7 January 2021

Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900215-1

7 January 2021

Prevalence of microalbuminuria in older-onset diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900215-1

7 January 2021

The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900215-1

7 January 2021

Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900215-1

7 January 2021

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900215-1

7 January 2021

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900215-1

7 January 2021

The progressive cost of complications in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900215-1

7 January 2021

Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900215-1

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900215-1

7 January 2021

10.1016/S0168-8227(00)00215-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11080561%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference